{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:32Z","timestamp":1792794812344,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870991"],"award-info":[{"award-number":["81870991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1603281"],"award-info":[{"award-number":["U1603281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08997-7","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:26:42Z","timestamp":1763468802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MIF downregulation attenuates neuroinflammation via TLR4\/MyD88\/TRAF6\/NF-\u03baB pathway to protect dopaminergic neurons in Parkinson\u2019s disease model"],"prefix":"10.1038","volume":"8","author":[{"given":"Yicong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-3701","authenticated-orcid":false,"given":"Shaogang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"8997_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"8997_CR2","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.3233\/JPD-223278","volume":"12","author":"M Saleh","year":"2022","unstructured":"Saleh, M., Markovic, M., Olson, K. E., Gendelman, H. E. & Mosley, R. L. Therapeutic Strategies for Immune Transformation in Parkinson\u2019s Disease. J. Parkinsons Dis. 12, S201\u2013S222 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"8997_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"8997_CR4","doi-asserted-by":"crossref","unstructured":"Kalia, L. & Lang, A. J. L. Parkinson\u2019s disease. The Lancet 386, 896\u2013912 (2015).","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"8997_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"8997_CR6","doi-asserted-by":"publisher","first-page":"4784268","DOI":"10.1155\/2018\/4784268","volume":"2018","author":"G Gelders","year":"2018","unstructured":"Gelders, G., Baekelandt, V. & Van der Perren, A. Linking Neuroinflammation and Neurodegeneration in Parkinson\u2019s Disease. J. Immunol. Res. 2018, 4784268 (2018).","journal-title":"J. Immunol. Res."},{"key":"8997_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R. M. How neuroinflammation contributes to neurodegeneration. Science 353, 777\u2013783 (2016).","journal-title":"Science"},{"key":"8997_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi, M. et al. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci. Lett. 211, 13\u201316 (1996).","journal-title":"Neurosci. Lett."},{"key":"8997_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki, B. et al. Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci. Lett. 441, 158\u2013162 (2008).","journal-title":"Neurosci. Lett."},{"key":"8997_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cyto.2011.03.027","volume":"55","author":"A Nicoletti","year":"2011","unstructured":"Nicoletti, A. et al. Parkinson\u2019s disease is associated with increased serum levels of macrophage migration inhibitory factor. Cytokine 55, 165\u2013167 (2011).","journal-title":"Cytokine"},{"key":"8997_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"8997_CR12","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1002\/ana.10485","volume":"53","author":"JH Kordower","year":"2003","unstructured":"Kordower, J. H. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson\u2019s disease. Ann. Neurol. 53, S120\u2013S134 (2003).","journal-title":"Ann. Neurol."},{"key":"8997_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuroscience.2007.02.055","volume":"147","author":"I Glezer","year":"2007","unstructured":"Glezer, I., Simard, A. R. & Rivest, S. Neuroprotective role of the innate immune system by microglia. Neuroscience 147, 867\u2013883 (2007).","journal-title":"Neuroscience"},{"key":"8997_CR14","doi-asserted-by":"publisher","first-page":"105000","DOI":"10.1016\/j.neuint.2021.105000","volume":"145","author":"Y Wu","year":"2021","unstructured":"Wu, Y., Jiao, Z., Wan, Z. & Qu, S. Role of autophagy and oxidative stress to astrocytes in fenpropathrin-induced Parkinson-like damage. Neurochem Int. 145, 105000 (2021).","journal-title":"Neurochem Int"},{"key":"8997_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block, M. L., Zecca, L. & Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57\u201369 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"8997_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964\u2013978 (2022).","journal-title":"Brain"},{"key":"8997_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura, K. et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta neuropathologica 106, 518\u2013526 (2003).","journal-title":"Acta neuropathologica"},{"key":"8997_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","volume":"909","author":"Y He","year":"2001","unstructured":"He, Y., Appel, S. & Le, W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909, 187\u2013193 (2001).","journal-title":"Brain Res."},{"key":"8997_CR19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu, D. C. et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763\u20131771 (2002).","journal-title":"J. Neurosci."},{"key":"8997_CR20","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","volume":"233","author":"K Sumaiya","year":"2022","unstructured":"Sumaiya, K., Langford, D., Natarajaseenivasan, K. & Shanmughapriya, S. Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies. Pharm. Ther. 233, 108024 (2022).","journal-title":"Pharm. Ther."},{"key":"8997_CR21","doi-asserted-by":"crossref","unstructured":"Pellowe, A.S., et al. Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation, 33, 2171\u20132186 (2019).","DOI":"10.1096\/fj.201800480R"},{"key":"8997_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cvr\/cvx025","volume":"113","author":"Y Fan","year":"2017","unstructured":"Fan, Y. et al. Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis. Cardiovascular Res. 113, 519\u2013530 (2017).","journal-title":"Cardiovascular Res."},{"key":"8997_CR23","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1073\/pnas.95.19.11383","volume":"95","author":"T Calandra","year":"1998","unstructured":"Calandra, T., Spiegel, L. A., Metz, C. N. & Bucala, R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl Acad. Sci. USA 95, 11383\u201311388 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8997_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/72262","volume":"6","author":"T Calandra","year":"2000","unstructured":"Calandra, T. et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164\u2013170 (2000).","journal-title":"Nat. Med."},{"key":"8997_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1365-2249.2002.01838.x","volume":"128","author":"H Murakami","year":"2002","unstructured":"Murakami, H., Akbar, S. M. F., Matsui, H., Horiike, N. & Onji, M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin. Exp. Immunol. 128, 504\u2013510 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"8997_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","volume":"57","author":"SS Jankauskas","year":"2019","unstructured":"Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S. & Boor, P. Evolving complexity of MIF signaling. Cell Signal 57, 76\u201388 (2019).","journal-title":"Cell Signal"},{"key":"8997_CR27","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1210\/en.2008-1088","volume":"150","author":"C Carli","year":"2009","unstructured":"Carli, C., Metz, C. N., Al-Abed, Y., Naccache, P. H. & Akoum, A. Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology 150, 3128\u20133137 (2009).","journal-title":"Endocrinology"},{"key":"8997_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/09680519030090020801","volume":"9","author":"T Roger","year":"2003","unstructured":"Roger, T., Froidevaux, C., Martin, C. & Calandra, T. Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4). J. endotoxin Res. 9, 119\u2013123 (2003).","journal-title":"J. endotoxin Res."},{"key":"8997_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/414920a","volume":"414","author":"T Roger","year":"2001","unstructured":"Roger, T., David, J., Glauser, M. P. & Calandra, T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920\u2013924 (2001).","journal-title":"Nature"},{"key":"8997_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jcb.26248","volume":"119","author":"Y Gao","year":"2018","unstructured":"Gao, Y. et al. Obacunone causes sustained expression of MKP-1 thus inactivating p38 MAPK to suppress pro-inflammatory mediators through intracellular MIF. J. Cell. Biochem. 119, 837\u2013849 (2018).","journal-title":"J. Cell. Biochem."},{"key":"8997_CR31","doi-asserted-by":"crossref","unstructured":"Cheng, J. et al. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy 16, 2193\u20132205 (2020).","DOI":"10.1080\/15548627.2020.1719723"},{"key":"8997_CR32","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares, M., I. Rojo, A., Manda, G., Bosc\u00e1, L. & Cuadrado, A. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells 9, 1687 (2020).","journal-title":"Cells"},{"key":"8997_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1439-y","volume":"16","author":"S Reden\u0161ek","year":"2019","unstructured":"Reden\u0161ek, S. et al. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson\u2019s disease. J. Neuroinflammation 16, 50 (2019).","journal-title":"J. Neuroinflammation"},{"key":"8997_CR34","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1021\/acschemneuro.5b00026","volume":"6","author":"T Chen","year":"2015","unstructured":"Chen, T., Hou, R., Xu, S. & Wu, C. Donepezil Regulates 1-Methyl-4-phenylpyridinium-Induced Microglial Polarization in Parkinson\u2019s Disease. ACS Chem. Neurosci. 6, 1708\u20131714 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"8997_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ymthe.2019.02.018","volume":"27","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice. Mol. Ther. : J. Am. Soc. Gene Ther. 27, 999\u20131016 (2019).","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"8997_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63778-y","volume":"10","author":"B Cheng","year":"2020","unstructured":"Cheng, B. et al. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Sci. Rep. 10, 6741 (2020).","journal-title":"Sci. Rep."},{"key":"8997_CR37","doi-asserted-by":"publisher","first-page":"24976","DOI":"10.1074\/jbc.M203220200","volume":"277","author":"JB Lubetsky","year":"2002","unstructured":"Lubetsky, J. B. et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277, 24976\u201324982 (2002).","journal-title":"J. Biol. Chem."},{"key":"8997_CR38","doi-asserted-by":"publisher","first-page":"36541","DOI":"10.1074\/jbc.C500243200","volume":"280","author":"Y Al-Abed","year":"2005","unstructured":"Al-Abed, Y. et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J. Biol. Chem. 280, 36541\u201336544 (2005).","journal-title":"J. Biol. Chem."},{"key":"8997_CR39","doi-asserted-by":"crossref","unstructured":"Swope, M., Sun, H. W., Blake, P. R. & Lolis, E. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J. 17, 3534\u20133541 (1998).","DOI":"10.1093\/emboj\/17.13.3534"},{"key":"8997_CR40","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acschemneuro.1c00076","volume":"12","author":"X Meng","year":"2021","unstructured":"Meng, X. et al. MiR-30a-5p Regulates GLT-1 Function via a PKCalpha-Mediated Ubiquitin Degradation Pathway in a Mouse Model of Parkinson\u2019s Disease. ACS Chem. Neurosci. 12, 1578\u20131592 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"8997_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","volume":"8","author":"J Li","year":"2022","unstructured":"Li, J. et al. Melatonin ameliorates Parkinson\u2019s disease via regulating microglia polarization in a RORalpha-dependent pathway. NPJ Parkinsons Dis. 8, 90 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"8997_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41401-019-0261-5","volume":"41","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. 6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo. Acta pharmacologica Sin. 41, 10\u201321 (2020).","journal-title":"Acta pharmacologica Sin."},{"key":"8997_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105221","volume":"152","author":"M Cai","year":"2022","unstructured":"Cai, M. et al. Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson\u2019s disease via inhibiting p38MAPK\/NF-\u03baB signaling pathway. Neurochem Int 152, 105221 (2022).","journal-title":"Neurochem Int"},{"key":"8997_CR44","doi-asserted-by":"crossref","unstructured":"Wang, R., Sun, H., Wang, G. & Ren, H. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson\u2019s Disease. Int. J. Mol. Sci. 21 (2020).","DOI":"10.3390\/ijms21197182"},{"key":"8997_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00401-008-0476-x","volume":"117","author":"Y Nishio","year":"2009","unstructured":"Nishio, Y. et al. Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice. Acta neuropathologica 117, 321\u2013328 (2009).","journal-title":"Acta neuropathologica"},{"key":"8997_CR46","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Macrophage migration inhibitory factor facilitates prostaglandin E(2) production of astrocytes to tune inflammatory milieu following spinal cord injury. J. Neuroinflammation 16, 85 (2019).","DOI":"10.1186\/s12974-019-1468-6"},{"key":"8997_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12253-016-0138-6","volume":"23","author":"CC Nobre","year":"2017","unstructured":"Nobre, C. C. et al. Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer. Pathol. Oncol. Res. : POR 23, 235\u2013244 (2017).","journal-title":"Pathol. Oncol. Res. : POR"},{"key":"8997_CR48","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354 (2016)","DOI":"10.1126\/science.aad6872"},{"key":"8997_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-021-04109-w","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis. Cell. Mol. life Sci. : CMLS 79, 60 (2022).","journal-title":"Cell. Mol. life Sci. : CMLS"},{"key":"8997_CR50","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.cell.2022.04.020","volume":"185","author":"H Park","year":"2022","unstructured":"Park, H. et al. PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson\u2019s disease. Cell 185, 1943\u20131959.e21 (2022).","journal-title":"Cell"},{"key":"8997_CR51","doi-asserted-by":"crossref","unstructured":"Matsunaga, J. et al. Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J. Biol. Chem. 274, 3268\u20133271 (1999).","DOI":"10.1074\/jbc.274.6.3268"},{"key":"8997_CR52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.apmr.2014.10.021","volume":"96","author":"M Bank","year":"2015","unstructured":"Bank, M. et al. Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury. Arch. Phys. Med. rehabilitation 96, 633\u2013644 (2015).","journal-title":"Arch. Phys. Med. rehabilitation"},{"key":"8997_CR53","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.neuroscience.2005.12.056","volume":"139","author":"M Chalimoniuk","year":"2006","unstructured":"Chalimoniuk, M., King-Pospisil, K., Metz, C. N. & Toborek, M. Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons. Neuroscience 139, 1117\u20131128 (2006).","journal-title":"Neuroscience"},{"key":"8997_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0342-4","volume":"12","author":"G Benedek","year":"2015","unstructured":"Benedek, G. et al. HLA-DR\u03b11-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection. J. neuroinflammation 12, 123 (2015).","journal-title":"J. neuroinflammation"},{"key":"8997_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10020-020-00163-5","volume":"26","author":"E Nasiri","year":"2020","unstructured":"Nasiri, E., et al. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer\u2019s disease. Mol. Med. (Camb., Mass.) 26, 34 (2020).","journal-title":"Mol. Med. (Camb., Mass.)"},{"key":"8997_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4155\/fmc.10.281","volume":"3","author":"Y Al-Abed","year":"2011","unstructured":"Al-Abed, Y. & VanPatten, S. J. F. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic. Future medicinal Chem. 3, 45\u201363 (2011).","journal-title":"Future medicinal Chem."},{"key":"8997_CR57","doi-asserted-by":"crossref","unstructured":"Petralia, M. C. et al. The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective? Molecules (Basel, Switzerland) 25 (2020).","DOI":"10.3390\/molecules25020291"},{"key":"8997_CR58","doi-asserted-by":"crossref","unstructured":"Li, S. Q. et al. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease. J. Neuroinflammation 12, 177 (2015).","DOI":"10.1186\/s12974-015-0396-3"},{"key":"8997_CR59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0039-1677803","volume":"119","author":"D Sinitski","year":"2019","unstructured":"Sinitski, D. et al. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation. Thrombosis Haemost. 119, 553\u2013566 (2019).","journal-title":"Thrombosis Haemost."},{"key":"8997_CR60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","volume":"23","author":"JB Bilsborrow","year":"2019","unstructured":"Bilsborrow, J. B., Doherty, E., Tilstam, P. V. & Bucala, R. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin. therapeutic targets 23, 733\u2013744 (2019).","journal-title":"Expert Opin. therapeutic targets"},{"key":"8997_CR61","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.3390\/ijms21207448","volume":"21","author":"MK Newell-Rogers","year":"2020","unstructured":"Newell-Rogers, M. K., Rogers, S. K., Tobin, R. P., Mukherjee, S. & Shapiro, L. A. Antagonism of Macrophage Migration Inhibitory Factory (MIF) after Traumatic Brain Injury Ameliorates Astrocytosis and Peripheral Lymphocyte Activation and Expansion. Int J. Mol. Sci. 21, 7448 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"8997_CR62","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1096\/fj.201800058R","volume":"32","author":"C Schmitz","year":"2018","unstructured":"Schmitz, C. et al. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J. : Off. Publ. Federation Am. Societies Exp. Biol. 32, 4428\u20134443 (2018).","journal-title":"FASEB J. : Off. Publ. Federation Am. Societies Exp. Biol."},{"key":"8997_CR63","doi-asserted-by":"crossref","unstructured":"Zheng, L. T. et al. Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312). Int. Immunopharmacol. 98, 107868 (2021).","DOI":"10.1016\/j.intimp.2021.107868"},{"key":"8997_CR64","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2016","unstructured":"Xu, L., He, D. & Bai, Y. Microglia-Mediated Inflammation and Neurodegenerative Disease. Mol. Neurobiol. 53, 6709\u20136715 (2016).","journal-title":"Mol. Neurobiol."},{"key":"8997_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet, S., Prinz, M. & van Loo, G. Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology. Trends Mol. Med 25, 112\u2013123 (2019).","journal-title":"Trends Mol. Med"},{"key":"8997_CR66","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam, T. I., Hinkle, J. T., Dawson, T. M. & Dawson, V. L. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol. Dis. 144, 105028 (2020).","journal-title":"Neurobiol. Dis."},{"key":"8997_CR67","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"8997_CR68","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat. Med. 24, 931\u2013938 (2018).","journal-title":"Nat. Med."},{"key":"8997_CR69","doi-asserted-by":"crossref","unstructured":"Dawson, V. L. & Dawson, T. M. Promising disease-modifying therapies for Parkinson\u2019s disease. Sci. Transl. Med. 11, (2019).","DOI":"10.1126\/scitranslmed.aba1659"},{"key":"8997_CR70","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1042\/CS20180041","volume":"132","author":"PC Chan","year":"2018","unstructured":"Chan, P. C. et al. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance. Clin. Sci. (Lond., Engl. : 1979) 132, 1581\u20131596 (2018).","journal-title":"Clin. Sci. (Lond., Engl. : 1979)"},{"key":"8997_CR71","doi-asserted-by":"publisher","first-page":"e113369","DOI":"10.1371\/journal.pone.0113369","volume":"9","author":"OM Finucane","year":"2014","unstructured":"Finucane, O. M. et al. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis. PLoS One 9, e113369 (2014).","journal-title":"PLoS One"},{"key":"8997_CR72","doi-asserted-by":"crossref","unstructured":"Wei, X. et al. Free heme induces neuroinflammation and cognitive impairment by microglial activation via the TLR4\/MyD88\/NF-\u03baB signaling pathway. Cell Commun. Signaling. CCS 22,16.","DOI":"10.1186\/s12964-023-01387-8"},{"key":"8997_CR73","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/00365540310015683","volume":"35","author":"S Akira","year":"2009","unstructured":"Akira, S. & Sato, S. Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis. 35, 555\u2013562 (2009).","journal-title":"Scand. J. Infect. Dis."},{"key":"8997_CR74","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.5995","volume":"258","author":"C V\u00e1zquez-Carballo","year":"2022","unstructured":"V\u00e1zquez-Carballo, C. et al. Role of Toll-like receptor 4 in intravascular hemolysis-mediated injury. J. Pathol. 258, 236\u2013249 (2022).","journal-title":"J. Pathol."},{"key":"8997_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02430-0","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4\/NF-kappaB signaling pathway. J. Neuroinflammation 19, 71 (2022).","journal-title":"J. Neuroinflammation"},{"key":"8997_CR76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fphar.2018.00028","volume":"9","author":"D Song","year":"2018","unstructured":"Song, D. et al. Asiaticoside Attenuates Cell Growth Inhibition and Apoptosis Induced by Abeta1-42 via Inhibiting the TLR4\/NF-kappaB Signaling Pathway in Human Brain Microvascular Endothelial Cells. Front Pharm. 9, 28 (2018).","journal-title":"Front Pharm."},{"key":"8997_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fncel.2017.00035","volume":"11","author":"M Shan","year":"2017","unstructured":"Shan, M. et al. TIR-Domain-Containing Adapter-Inducing Interferon-beta (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1\/M2 Modulation. Front Cell Neurosci. 11, 35 (2017).","journal-title":"Front Cell Neurosci."},{"key":"8997_CR78","doi-asserted-by":"crossref","unstructured":"Taticchi, A. et al. In Vitro Anti-Inflammatory Effects of Phenolic Compounds from Moraiolo Virgin Olive Oil (MVOO) in Brain Cells via Regulating the TLR4\/NLRP3 Axis. Molecules (Basel, Switzerland) 24 (2019).","DOI":"10.3390\/molecules24244523"},{"key":"8997_CR79","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.fct.2010.05.002","volume":"48","author":"MS Ju","year":"2010","unstructured":"Ju, M. S. et al. Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson\u2019s disease models. Food Chem. Toxicol. 48, 2037\u20132044 (2010).","journal-title":"Food Chem. Toxicol."},{"key":"8997_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1236-z","volume":"15","author":"C Qiao","year":"2018","unstructured":"Qiao, C. et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson\u2019s disease. J. Neuroinflammation 15, 193 (2018).","journal-title":"J. Neuroinflammation"},{"key":"8997_CR81","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang, S. et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53, D1670\u2013D1676 (2025).","journal-title":"Nucleic Acids Res"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08997-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08997-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08997-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T01:03:54Z","timestamp":1763514234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08997-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8997"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08997-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1595"}}